Reata Pharmaceuticals, Inc. (RETA)

Trade RETA now with
12/8/2021 7:40:35 AM Reata Pharma: FDA Advisory Committee To Discuss Bardoxolone For Chronic Kidney Disease Caused By Alport Syndrome
3/1/2021 6:41:50 AM Reata Pharma FY GAAP Loss Per Share $7.35; Non-GAAP Loss Per Share $4.70
7/7/2020 6:50:03 AM Reata Promotes Colin Meyer To Newly Created Position Of Chief Research And Development Officer And EVP
6/24/2020 10:16:12 AM Reata Reports Receipt Of $350 Mln Related To Closing Of Investment From Blackstone Life Sciences